Diagnostic value of JAK 2 V 617 F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: The JAK 2 V 617 F somatic mutation is present in the majority of patients with myeloproliferative cancer (polycythaemia vera, essential thrombocytosis, and primary myelofibrosis). However, the diagnostic value of the JAK 2 V 617 F somatic mutation for myeloproliferative cancer in the general population is unknown. We examined this question in 49 488 individuals from the C openhagen G eneral P opulation S tudy. We also examined the association between JAK 2 V 617 F somatic mutation, rs10974944 germline genotype, haematological phenotype, any cancer, haematological cancer, myeloproliferative cancer, ischaemic heart disease, and venous thromboembolism. The JAK 2 V 617 F somatic mutation was present in 0·1% (n = 68), increasing across rs10974944 germline genotypes (P‐trend = 0·001). JAK 2 V 617 F somatic mutation positives versus negatives had higher erythrocyte (P = 2 × 10−5), thrombocyte (P = 2 × 10−16), and leucocyte (P = 4 × 10−9) counts, and had 2·7‐/2·5‐fold risk of cancer (prevalent/incident), 44‐/28‐fold risk of haematological cancer, 221‐/97‐fold risk of myeloproliferative cancer, 2·2‐/1·2‐fold risk of ischaemic heart disease, and 3·1‐/1·0‐fold risk of venous thromboembolism. By combining conventional haematological parameters with a test for the JAK 2 V 617 F somatic mutation, myelo;?>proliferative cancer could be identified or ruled out with a sensitivity of 47–100% and a specificity of 98–100%. In conclusion, in the general population the JAK 2 V 617 F somatic mutation has a high diagnostic value for myeloproliferative cancer when combined with conventional haematological parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationGenetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
Self-citation
Cited by
Life histories of myeloproliferative neoplasms inferred from phylogenies
Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A., Godfrey, A. L., Green, A. R., et al. (2022) · Nature · doi:10.1038/s41586-021-04312-6 · Cited by 285
Hinds, D. A., Barnholt, K. E., Mesa, R. A., Kiefer, A. K., Do, C. B., Eriksson, N., Mountain, J. L., Francke, U., Tung, J. Y., Nguyen, H. (., et al. (2016) · Blood · doi:10.1182/blood-2015-06-652941 · Cited by 267
“In general population studies, the V617F mutation has also been identified in subjects without a diagnosed MPN or other overt hematologic disorder.(21-29) Although the clinical significance of V617F positivity (eg, JAK2 V617F-mutant clonal hematopoiesis) in this context is unclear, some of these analyses have begun to…”
BackgroundJAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
Sano, S., Wang, Y., Yura, Y., Sano, M., Oshima, K., Yang, Y., Katanasaka, Y., Min, K.-D., Matsuura, S., Ravid, K., et al. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.013 · Cited by 170
Metadata
- Authors
- Nielsen, C., Birgens, H. S., Nordestgaard, B. G., & Bojesen, S. E.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2012-11
- Volume
- 160
- Issue
- 1
- Pages
- 70-79
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1989567509
- Cited by
- 109
- References
- 2
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic value of JAK 2 V 617 F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population. https://app.cochat.ai/papers/10.1111/bjh.12099
- The paper
- Nielsen, C., Birgens, H. S., Nordestgaard, B. G., & Bojesen, S. E. (2013). Diagnostic value of JAK 2 V 617 F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population. British Journal of Haematology. https://doi.org/10.1111/bjh.12099
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.